Mersana Therapeutics Profit Margin 2016-2022 | MRSN
Current and historical gross margin, operating margin and net profit margin for Mersana Therapeutics (MRSN) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Mersana Therapeutics net profit margin as of September 30, 2022 is -1749.59%.
|Mersana Therapeutics Annual Profit Margins
|Mersana Therapeutics Quarterly Profit Margins
||Medical - Biomedical and Genetics
Mersana Therapeutics, Inc. is a biotechnology company. It focused on discovering and developing a pipeline of antibody drug conjugates. The company's product candidates include XMT-1522 and XMT-1536 which are in clinical stage. Mersana Therapeutics, Inc. is based in CAMBRIDGE, United States.